-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
2,3-Dihydroxyquinoxaline is a benzoxazepine derivative that has been shown to exhibit a wide range of biological activities, including antioxidant, antinflammatory, and anticancer properties.
The compound has gained increasing attention in recent years due to its potential therapeutic applications.
In this article, we will discuss the production process of 2,3-dihydroxyquinoxaline, including the synthesis, purification, and characterization of the compound.
Synthesis of 2,3-dihydroxyquinoxaline
There are several synthesis methods for 2,3-dihydroxyquinoxaline, including the classical method using benzoyl chloride and the more recent microwave-assisted method.
The classical method involves the reaction of para-nitrophenol with benzoyl chloride in the presence of an acid catalyst, yielding an intermediate acid, which is then treated with a base to form the 2,3-dihydroxyquinoxaline.
This method requires the use of hazardous reagents and solvents and is accompanied by a series of complicated and time-consuming steps.
The microwave-assisted method, on the other hand, is a more efficient and environmentally friendly approach.
It involves the reaction of para-nitrophenol with benzoyl chloride in the presence of a microwave catalyst, such as Zr(SO4)2, and a polar protic solvent, such as water or methanol.
The reaction is carried out under mild conditions, and the product can be conveniently extracted and purified using a simple protocol.
Purification of 2,3-dihydroxyquinoxaline
The purification of 2,3-dihydroxyquinoxaline is essential to ensure its suitability for pharmaceutical applications.
The compound can be purified using various methods, including crystallization, recrystallization, filtration, and chromatography.
Crystallization involves dissolving the product in a suitable solvent and allowing the crystals to form spontaneously.
The crystals can then be collected, washed, and dried to obtain pure 2,3-dihydroxyquinoxaline.
Recrystallization involves dissolving the product in a polar solvent and allowing the crystals to form by cooling or by adding a nonsolvent.
The crystals can then be collected, washed, and dried to obtain pure 2,3-dihydroxyquinoxaline.
Filtration involves passing the reaction mixture through a filter paper to remove any impurities.
The filtrate can then be collected and purified using other methods, such as crystallization or chromatography.
Chromatography involves dissolving the product in a suitable solvent and passing it through a column packed with a stationary phase.
The components of the mixture can then be separated based on their differences in adsorption or desorption to the stationary phase.
2,3-dihydroxyquinoxaline can be purified using high-performance liquid chromatography (HPLC), which is a widely used method in the pharmaceutical industry.
Characterization of 2,3-dihydroxyquinoxaline
The characterization of 2,3-dihydroxyquinoxaline is essential to confirm its identity and purity.
The compound can be characterized using various methods, including spectroscopic techniques, such as infrared (IR) spectroscopy and nuclear magnetic resonance (NMR) spectroscopy, and elemental analysis, such as atomic absorption spectrometry (AAS) and inductively coupled plasma mass spectrometry (ICP-MS).
IR spectroscopy involves recording the absorption